Similarly, in HNSCC cell lines, CD44+ CSCs exhibit low levels of HLA-A2, HLA-II, and antigen processing 2 (TAP2) expression, making it difficult for cytotoxic T cells (CTLs) or NK cells to identify the CD44+ CSCs25,26. Here, CD44 is linked to head and neck squamous cell carcinoma.